Evidence map›Paper›PMID 10510090›Full record

ArticleThe Journal of experimental medicine1999

Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets.

M Eriksson, G Leitz, E Fällman, O Axner, J C Ryan, M C Nakamura, C L Sentman

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  18. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M ErikssonUmeå Center for Molecular Pathogenesis (UCMP), Umeå University, S-901 87 Umeå, Sweden. mikael.eriksson@ucmp.umu.se
G Leitz
E Fällman
O Axner
J C Ryan
M C Nakamura
C L Sentman

Funding

CONTROL OF ALLOGENIC NK CELL LYSIS BY LECTIN RECEPTORSR01AI044126 · NIAID · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI RYAN, JAMES C · 1999 to 2003
$1.1M
NIAID NIH HHS R01 AI044126NIAID NIH HHS R01 AI44126
6 · The paper itself

Abstract

Inhibitory receptors expressed on natural killer (NK) cells abrogate positive signals upon binding corresponding major histocompatibility complex (MHC) class I molecules on various target cells. By directly micromanipulating the effector-target cell encounter using an optical tweezers system which allowed temporal and spatial control, we demonstrate that Ly49-MHC class I interactions prevent characteristic cellular responses in NK cells upon binding to target cells. Furthermore, using this system, we directly demonstrate that an NK cell already bound to a resistant target cell may simultaneously bind and kill a susceptible target cell. Thus, although Ly49-mediated inhibitory signals can prevent many types of effector responses, they do not globally inhibit cellular function, but rather the inhibitory signal is spatially restricted towards resistant targets.

Indexed as

Cytotoxicity, ImmunologicAnimalsB-LymphocytesCell LineHistocompatibility Antigens Class IKiller Cells, NaturalLeukemia, ExperimentalMicroscopy, VideoModels, ImmunologicalRatsTumor Cells, CulturedHistocompatibility Antigens Class I

Identifiers

PMID10510090
PMCPMC2195645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.